Cardiovascular exercise complements strength training but should not replace it or dominate your routine
The Regulatory Reality of 2026: What Actually Changed In late 2023, the FDA moved 19 peptides, including BPC-157, to what's known as "Category 2" status under its framework for bulk drug substances used in compounding, identifying them as substances that "may present significant safety risks." The concern, as stated in FDA guidance, centered on the limited large-scale human data and questions about immunogenicity
by Wirecutter Staff Red light devices promise a lot but do they deliver
[DOI] [PubMed] [Google Scholar] 71.Mishima M., Wakita Y., Nakano M
I 2 = 0%), or vomiting (OR: 8.22, 95% CI: 4.02, 16.81
But as with any medical revolution, the meteoric rise of these drugs has brought a complex mix of life-changing benefits, dangerous side effects, and a booming, highly illegal shadow market